Dale Shultz

Swedish Medical Center

Papers

2

Total Citations

41

H-Index

2

About

Dale Shultz is a pioneering cardiothoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for thymoma and other mediastinal tumors. His most notable contribution challenges conventional size-based restrictions on robotic thymoma resection, demonstrating that tumors 3 cm and larger can be safely removed with robotic assistance. In his landmark 2016 study, Shultz showed that robotic resection of these larger thymomas is associated with remarkably low perioperative morbidity and mortality, effectively expanding the boundaries of what was previously considered feasible for minimally invasive approaches. This work, which has accumulated over 40 citations, provides critical evidence that tumor size alone should not preclude patients from benefiting from robotic surgery's advantages, including reduced pain, shorter hospital stays, and faster recovery. Shultz's findings have helped reshape clinical decision-making, offering surgeons a validated alternative to traditional open sternotomy for larger thymic neoplasms. By systematically evaluating outcomes in this previously understudied population, he has contributed meaningful data to the ongoing evolution of thoracic surgical oncology, making robotic resection a viable option for a broader spectrum of patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
41
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Resection of 3 Cm and Larger Thymomas is Associated with Low Perioperative Morbidity and Mortality
35 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Swedish Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago